Dolby Laboratories (DLB) Total Non-Current Liabilities (2009 - 2026)
Dolby Laboratories' (DLB) quarterly Total Non-Current Liabilities came in at $477.4 million in Q2 2026, up 7.04% YoY from $446.0 million in Q2 2025, and down 11.35% on a QoQ basis from $538.5 million in Q1 2026.
Dolby Laboratories (DLB) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Dolby Laboratories (DLB) has 18 years of Total Non-Current Liabilities data on file, last reported at $477.4 million in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 7.04% year-over-year to $477.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $477.4 million (up 7.04% YoY) and the FY2025 annual result came in at $496.0 million, up 1.8% from the prior year.
- Total Non-Current Liabilities retreated to $477.4 million in Q2 2026, from $538.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $538.5 million in Q1 2026 to a low of $338.4 million in Q3 2022.
- A 5-year average of $452.4 million and a median of $482.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 47.53% — and 2024, when it retreated 15.05%.
- Tracing DLB's Total Non-Current Liabilities over 5 years: stood at $347.4 million in 2022, then soared by 33.97% to $465.4 million in 2023, then increased by 9.02% to $507.4 million in 2024, then dropped by 1.65% to $499.0 million in 2025, then retreated by 4.33% to $477.4 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $477.4 million (Q2 2026), $538.5 million (Q1 2026), and $499.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.69 Bn | 81.40 Bn | 1.48 Bn | 2.70 Bn |
| 2 | Relx | 64.97 Bn | 64.80 Bn | - | 8.47 Bn |
| 3 | Copart | 32.09 Bn | 28.74 Bn | 732.88 Mn | 852.28 Mn |
| 4 | Global Payments | 24.80 Bn | 19.40 Bn | 2.03 Bn | 38.53 Bn |
| 5 | Rb Global | 16.24 Bn | 15.72 Bn | 935.50 Mn | 6.28 Bn |
| 6 | Aramark | 15.68 Bn | 15.18 Bn | 430.34 Mn | 13.32 Bn |
| 7 | UL Solutions | 15.20 Bn | 14.77 Bn | 417.00 Mn | 1.41 Bn |
| 8 | Rentokil Initial | 11.80 Bn | 9.27 Bn | - | -6.00 Mn |
| 9 | Dolby Laboratories | 6.05 Bn | 5.38 Bn | 264.68 Mn | 477.38 Mn |
| 10 | Unifirst | 5.23 Bn | 5.06 Bn | 234.73 Mn | 493.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 477.38 Mn |
| Mar 27, 2026 | 538.52 Mn |
| Dec 26, 2025 | 498.98 Mn |
| Sep 26, 2025 | 495.97 Mn |
| Jun 27, 2025 | 445.97 Mn |
| Mar 28, 2025 | 516.81 Mn |
| Dec 27, 2024 | 507.38 Mn |
| Sep 27, 2024 | 487.18 Mn |
| Jun 28, 2024 | 425.80 Mn |
| Mar 29, 2024 | 517.07 Mn |
| Dec 29, 2023 | 465.41 Mn |
| Sep 29, 2023 | 499.24 Mn |
| Jun 30, 2023 | 501.21 Mn |
| Mar 31, 2023 | 371.98 Mn |
| Dec 30, 2022 | 347.40 Mn |
| Sep 30, 2022 | 338.41 Mn |
| Jul 1, 2022 | 354.09 Mn |
| Apr 1, 2022 | 353.72 Mn |
| Dec 31, 2021 | 360.02 Mn |
| Sep 24, 2021 | 396.15 Mn |